Remove Blood Stasis Moxa Sticks

Name: Remove Blood Stasis Moxa Sticks
Brand: Hefei Amedcare Import and Export Trade Co., Ltd.
SKU: 2196511075

Anhui, ChinaHefei Amedcare Import and Export Trade Co., Ltd.

US$1.60

100-499 box

US$1.50

500-999 box

US$1.40

1,000+ box

Sample price:US$1.60/box.Request sample

Product profile

Customization

Available

Shape

Long

Function

Treatment Dysmenorrhea

Model NO.

Moxa Stick

Application

for External Use Fumigation

Usage Mode

For external use

Suitable for

Elderly, Children, Adult

State

Cylindrical

Nature

Yes

English Name

Moxa Sticks

Chinese Name

Ai Tiao

Customized

Transport Package

10sticks/Box*100boxes/Carton

Specification

18*200mm

Trademark

AMK

Origin

China

Production Capacity

5000boxes/Day

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceSelf-branded

Hefei Amedcare Import and Export Trade Co., Ltd.

Anhui, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤4.03h

AI-Powered supplier vetting

SummaryThe supplier, Hefei Amedcare Import & Export Trade Co., Ltd., is involved in the production and export of pharmaceutical products. They offer OEM and ODM services, demonstrated strong service capability, and have a set structure for dealing with customer complaints. Although they lack overseas warehouses or agents, they have participated in international trade shows. Financially, they have shown consistent performance over the past three years. Their production capability is significant with a high annual output, but they operate only one production line. Their R&D efforts are active, with new products launched in the past year, but there is no available SDK for development.

Supplier typeHefei Amedcare Import & Export Trade Co., Ltd. is a foreign trade department of Anhui Topsun Pharmaceutical Co. Ltd., focusing on drug production, R&D, and sales.

CertificationsThe supplier's production has passed through GMP quality system certification and follows GMP standards for production and inspection.

After-Sales capabilityThe supplier has clear procedures and records for handling complaints, and offers to address quality problems within the product validity period.

Financial creditThe financial records indicate consistent performance over the last three years, with data available for 2022, 2023, and 2024.

R&D capabilityThe supplier has an active R&D capability with new products developed in the past year, though no SDK is available.

Production capacityThe supplier operates one production line with a significant annual production output of over US$100 million.

Customization capabilityThe supplier offers extensive customization options including full and minor customization, ODM, and OEM services.